Effects of anti-drug antibody on clinical efficacy and adverse reactions of immunotherapy for non-small cell lung cancer

Effects of anti-drug antibody on clinical efficacy and adverse reactions of immunotherapy for non-small cell lung cancer

Objective To explore the effects of anti-drug antibody (ADA) on clinical efficacy and adverse reactions in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). Methods A total of 26 patients with stage Ⅲ/Ⅳ NSCLC undergoing pembrolizumab or nivolumab trea...

Full description

Bibliographic Details
Main Authors: ZHAO Xianlan, LI Jixi, YANG Qiao, LI Shixun, YU Yongxin, LI Feng, LI Mengxia, SUN Jianguo
Format: Article
Language:zho
Published: Editorial Office of Journal of Third Military Medical University 2021-09-01
Series:Di-san junyi daxue xuebao
Subjects:
non-small cell lung cancer
anti-drug antibody
immune checkpoint inhibitors
immune-related adverse events
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/202103060.htm

Internet

http://aammt.tmmu.edu.cn/Upload/rhtml/202103060.htm

Similar Items